Antimitotic Agents: all 5,052 studies that test it

Page 47 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate CancerCompletedNCT00031187Phase 2
• Kanglaite Injection Phase I StudyCompletedNCT00031031Phase 1
• Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLCCompletedNCT00030810Phase 2
• Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00030706Phase 2
• Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00030654Phase 3
• Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00030641Phase 2/3
• Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00030420Phase 2
• Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00030407Phase 2
• Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00030368Phase 1
• A Trial to Evaluate Epothilone D in Patients With Advanced Solid TumorsCompletedNCT00030173Phase 1
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 1
• Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder UrotheliumCompletedNCT00028756Phase 3
• PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00028587Phase 1
• BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid TumorsTerminatedNCT00028561Phase 1
• Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsCompletedNCT00028535Phase 1
• Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerTerminatedNCT00028483Phase 2
• Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00027859Phase 3
• S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00026156Phase 2
• Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00026104Phase 2
• Docetaxel and Ifosfamide in Treating Women With Metastatic Breast CancerStatus unknownNCT00026078Phase 2
• Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast CancerStatus unknownNCT00025688Phase 3
• S0029 Docetaxel in Treating Older Women With Metastatic Breast CancerTerminatedNCT00025493Phase 2
• Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerCompletedNCT00025389Phase 2
• Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaCompletedNCT00025363Phase 2
• Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate CancerCompletedNCT00025194Phase 1/2
• DHA-Paclitaxel in Treating Patients With Metastatic Prostate CancerStatus unknownNCT00024414Phase 2
• DHA-Paclitaxel in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00024401Phase 2
• Chemotherapy in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00024388Phase 2
• DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic CancerStatus unknownNCT00024375Phase 2
• Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid TumorsStatus unknownNCT00024310Phase 1
• BMS-247550 in Treating Patients With Liver or Gallbladder CancerTerminatedNCT00023946Phase 2
• Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerTerminatedNCT00023907Phase 2
• Carbendazim in Treating Patients With Advanced Solid Tumors or LymphomaStatus unknownNCT00023816Phase 1
• Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & LymphomasTerminatedNCT00023166Phase 1
• Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial CancerCompletedNCT00022620Phase 2
• Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related LymphomaCompletedNCT00022555Phase 1
• BMS-247550 in Treating Patients With Advanced Soft Tissue SarcomaTerminatedNCT00022542Phase 2
• BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00022477Phase 2
• T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous ChemotherapyStatus unknownNCT00022243Phase 2
• Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck CancerStatus unknownNCT00022217Phase 2
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract CancerCompletedNCT00022191Phase 3
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of OriginStatus unknownNCT00022178Phase 3
• Vinorelbine in Treating Older Women With Stage IV Breast CancerCompletedNCT00022152Phase 2
• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00022139Phase 2
• Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaCompletedNCT00022126Phase 2
• Docetaxel in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00022022Phase 3
• Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00021372Phase 2
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung CancerCompletedNCT00021333Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00021320Phase 2
• Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid LeukemiaCompletedNCT00021242Phase 2
• Ixabepilone in Treating Patients With Advanced Urinary Tract CancerCompletedNCT00021099Phase 2
• BMS-247550 in Treating Women With Metastatic Breast CancerCompletedNCT00020904Phase 2
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachCompletedNCT00020761Phase 2
• BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous TherapyCompletedNCT00020371Phase 1
• Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00020332Phase 1/2
• Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerCompletedNCT00020046Phase 2
• Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By SurgeryCompletedNCT00020007Phase 1
• Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2CompletedNCT00019812Phase 2
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasCompletedNCT00019019Phase 1
• Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00017459Phase 3
• Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00017407Phase 3
• Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast CancerCompletedNCT00017394Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed NeuroblastomaCompletedNCT00017368Phase 2
• Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal CancerStatus unknownNCT00017303Phase 2
• Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast CancerCompletedNCT00017095Phase 3
• BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With ChemotherapyCompletedNCT00017056Phase 2
• BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With ChemotherapyCompletedNCT00017043Phase 2
• BMS-247550 in Treating Patients With Advanced Pancreatic CancerCompletedNCT00016965Phase 2
• PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusCompletedNCT00016900Phase 2
• 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic CancerCompletedNCT00016874Phase 1
• BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00016393Phase 2
• Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerTerminatedNCT00016341Phase 3
• Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung CancerCompletedNCT00016315Phase 1
• Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal CancerCompletedNCT00016250Phase 2
• Flavopiridol and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00016185Phase 1
• Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate CancerCompletedNCT00016107Phase 2
• S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerCompletedNCT00015938Phase 2
• Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With SurgeryCompletedNCT00015886Phase 2
• Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic LeukemiaCompletedNCT00015873Phase 3
• Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the VulvaCompletedNCT00014599Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
• Chemotherapy Plus Trastuzumab in Treating Patients With Breast CancerCompletedNCT00014430Phase 1
• Ro 31-7453 in Treating Patients With Metastatic Solid TumorsCompletedNCT00014365Phase 1
• Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate CancerCompletedNCT00014352Phase 2
• Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumCompletedNCT00014274Phase 2/3
• S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung CancerTerminatedNCT00014196Phase 2
• Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the PancreasCompletedNCT00012220Phase 2
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck CancerCompletedNCT00011999Phase 2
• Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone SurgeryCompletedNCT00011960Phase 2
• Benzoylphenylurea in Treating Patients With Advanced CancerTerminatedNCT00010205Phase 1
• Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00010140Phase 3
• Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast CancerCompletedNCT00009997Phase 1
• Combination Chemotherapy in Treating Patients With Solid TumorsStatus unknownNCT00009932Phase 1
• Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or StomachCompletedNCT00009880Phase 2
• Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid TumorsWithdrawnNCT00009828Phase 1
• Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00009802Phase 1
• Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaStatus unknownNCT00009776Phase 1
• Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast CancerStatus unknownNCT00009763Phase 1
• Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00009750Phase 1
• Docetaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00008411Phase 3

← Antimitotic Agents overview